3 recruiting, 2 completed, 2 unknown, 1 active not recruiting. 7 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 2, Recruiting 2, Active not recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Floxuridine (FUDR): new trials by email Literature Review of Floxuridine (FUDR) trials Research Report on Floxuridine (FUDR)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma Hepatic Artery Infusion Pump (HAIP), Floxuridine (FUDR) - Pancreas Cancer With Hepatic Metastase, Pancreas Adenocarcinoma | Recruiting | AdventHealth | 10 | 2026-11-01 | 2026-09-29 | |
| Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery Gemcitabine, Oxaliplatin, Dexamethasone - Intrahepatic Cholangiocarcinoma | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 164 | 2021-05-07 | 2026-10-22 |
| A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma Medtronic pump and Codman catheter, Floxuridine (FUDR), Gemcitabine - Colorectal Cancer, Cholangiocarcinoma | Phase 2 | Unknown | Benaroya Research Institute | 100 | 2020-11-25 | 2020-12-21 |
| Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases Floxuridine (FUDR), Hepatic Artery Infusion Pump, Heparinized Saline - Pancreatic Adenocarcinoma, Liver Metastases | Phase 2 | Active not recruiting | Corewell Health West | 14 | 2019-02-05 | 2026-07-16 |
| A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma Medtronic pump and Codman catheter, Floxuridine (FUDR), Gemcitabine - Colorectal Cancer, Cholangiocarcinoma | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 35 | 2018-10-18 | 2026-02-06 |
| Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver Floxuridine (FUDR), Irinotecan (CPT-11), FLUOROURACIL - Colorectal Adenocarcinoma Metastatic to the Liver | Phase 2 | Withdrawn | Memorial Sloan Kettering Cancer Center | 2017-02-28 | 2019-05-21 | |
| Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis Floxuridine (FUDR) - Colorectal Adenocarcinoma Metastatic in the Liver, Liver Metastasis Colon Cancer | Phase 2 | Recruiting | Sunnybrook Health Sciences Centre | 200 | 2014-07-01 | 2026-08-14 |
| A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver Metastasis mFOLFOX6, HAI - Metastatic Colorectal Cancer | Phase 3 | Unknown | Yuhong Li | 142 | 2014-03-01 | 2024-03-04 |
| Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) Floxuridine (FUDR), dexamethasone, Gemcitabine - Intrahepatic Cholangiocarcinoma, Peripheral Cholangiocarcinoma | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 56 | 2013-05-01 | 2026-07-01 |
Cholangiocarcinoma (4) · Colorectal Neoplasms (3) · Pancreatic Neoplasms (2) · Carcinoma, Pancreatic Ductal (1) · Duodenal Neoplasms (1)
Memorial Sloan Kettering Cancer Center (4) · AdventHealth (1) · Benaroya Research Institute (1) · Corewell Health West (1) · Sunnybrook Health Sciences Centre (1) · Yuhong Li (1)
United States (7) · Canada (1) · China (1) · Netherlands (1)
Andrea Cercek, MD (2) · G. Paul Wright, MD (1) · Hagen Kennecke, MD (1) · Nancy Kemeny, MD (1) · William Jarnagin, MD (1) · Yu-hong Li, MD, Ph D (1)